Skip to main content

Current Hematologic Malignancy Reports OnlineFirst articles

27.03.2024

Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström Macroglobulinemia

Waldenström macroglobulinemia (WM) is a rare indolent, low-grade B cell lymphoma that accounts for 1–2% of hematologic malignancies and is characterized by lymphoplasmacytic infiltration of the bone marrow and circulating monoclonal immunoglobulin …

verfasst von:
Reema K. Tawfiq, Jithma P. Abeykoon, Prashant Kapoor

07.03.2024

Update on T-Cell Lymphoma Epidemiology

T-cell lymphomas (TCLs) are a rare and diverse subgroup of non-Hodgkin lymphoma (NHL) characterized by the clonal expansion of mature T-lymphocytes. Traditionally, TCLs are classified into systemic peripheral T-cell lymphomas (PTCLs) which present …

verfasst von:
Jane J. Chen, Franco Castillo Tokumori, Christina Del Guzzo, Jeanyoung Kim, Jia Ruan

Open Access 05.03.2024

Management of Patients with Early Myelofibrosis: A Discussion of Best Practices

Myelofibrosis (MF) is a progressive myeloproliferative neoplasm (MPN) characterized by bone marrow reticulin and/or collagen fibrosis with megakaryocytic proliferation and atypia [ 1 ]. Somatic driver mutations in JAK2 , CALR , or MPL occur in most …

verfasst von:
Prithviraj Bose

23.02.2024

Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Strategies to Optimize Success and New Directions

Chronic myeloid leukemia (CML) is caused by the occurrence in the hematopoietic stem cell (HSC) pool of a reciprocal translocation between chromosome 9 and 22, the t(9;22)(q34;q11) [ 1 ]. This translocation generates a fusion between the BCR and …

verfasst von:
Delphine Rea, Sofiane Fodil, Etienne Lengline, Emmanuel Raffoux, Jean-Michel Cayuela

05.02.2024

Pulmonary, Hepatic, and Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Telomere Biology Disorders

Telomere biology disorders (TBDs) are multisystemic disorders which clinically present at degrees of organ involvement such as bone marrow failure (BMF), interstitial lung disease (ILD), non-regenerative hyperplasia (NRH) and/or cirrhosis, and T …

verfasst von:
Kelly M. Pennington, Douglas Simonetto, Timucin Taner, Abhishek A. Mangaonkar

Open Access 30.12.2023

Diagnosis and Management of Pulmonary Manifestations of Telomere Biology Disorders

Telomere biology disorders (TBDs) are a heterogeneous group of genetic conditions characterized by accelerated aging of somatic cells due to prematurely shortened telomere lengths, frequently leading to organ dysfunction [ 1 •, 2 ]. They are also …

verfasst von:
Kathryn T. del Valle, Eva M. Carmona